FRANÇAIS
A showcase of ÉTS researchers’ publications and other contributions
SEARCH

In vitro and pilot in vivo evaluation of a bioactive coating for stent grafts based on chondroitin sulfate and epidermal growth factor

Downloads

Downloads per month over past year

Lequoy, Pauline, Savoji, Houman, Saoudi, Bachir, Bertrand-Grenier, Antony, Wertheimer, Michael R., De Crescenzo, Gregory, Soulez, Gilles et Lerouge, Sophie. 2016. « In vitro and pilot in vivo evaluation of a bioactive coating for stent grafts based on chondroitin sulfate and epidermal growth factor ». Journal of Vascular and Interventional Radiology, vol. 27, nº 5. 753-760.e753.
Compte des citations dans Scopus : 4.

[img]
Preview
PDF
Lerouge S. 2016 12584 In vitro and pilot in vivo evaluation.pdf - Accepted Version

Download (1MB) | Preview

Abstract

Purpose: To evaluate the potential of a bioactive coating based on chondroitin sulfate (CS) and tethered epidermal growth factor (EGF) for the improvement of healing around stent-grafts (SG). Methods: The impact of the bioactive coating on cell survival was tested in vitro on human vascular cells using polyethylene terephtalate films (PET) as a substrate. After being transferred onto a more “realistic” material (expanded poly(tetrafluoroethylene), ePTFE), the durability and mechanical behavior of the coating in addition to cell survival were studied. Preliminary in vivo testing was performed in a canine iliac aneurysm model reproducing type I endoleaks (3 animals with 1 control and 1 bioactive SG for each). Results: The CS and EGF coatings significantly increased survival of human smooth muscle cells and fibroblasts, compared with bare PET or ePTFE (P<.05). The coating also displayed good durability over 30 days according to ELISA and cell-survival tests. The coating did not affect the mechanical properties of ePTFE and was successfully transferred onto commercial SG for in vivo testing. According to CT-scan and macroscopic examinations, no difference was observed in endoleak persistence at three months, but the bioactive coating deposited on the abluminal surface of the SG (exposed to the vessel wall) increased the percentage of healed tissue in the aneurysm. Moreover, no adverse effect such as neointima formation or thrombosis was observed. Conclusion: The bioactive coating promoted in vitro cell survival, displayed good durability and was successfully transferred onto a commercial SG. Preliminary in vivo results suggest improved healing around bioactive SG.

Item Type: Peer reviewed article published in a journal
Professor:
Professor
Lerouge, Sophie
Affiliation: Génie mécanique
Date Deposited: 10 May 2016 16:27
Last Modified: 17 Jan 2020 20:48
URI: https://espace2.etsmtl.ca/id/eprint/12584

Actions (login required)

View Item View Item